A Single Oral Escalating Dose Study of GSK2140944 in Healthy Volunteers
NCT02202187
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Infections, Respiratory Tract
Interventions
DRUG:
GSK2140944
OTHER:
Placebo
Sponsor
GlaxoSmithKline